🕵️ Cadrenal Therapeutics, Inc. ($CVKD)
SEC insider & ownership activity, last 12 months · CIK 1937993 · every row links its SEC filing
Over the last 12 months insiders sold $1.1M with no open-market buying against it. Quang X. Pham sold $701K through a program of 12 sale notices averaging $64K (Aug–Jun). No red-flag 8-Ks in the window.
🚨 7 signals active —
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 2 sellers, $1.1M (45 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Quang X. Pham | 0 | – | 33 | $701K | Jun 29, 2026 |
| Matthew K. Szot | 0 | – | 12 | $397K | Dec 29, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Quang X. Pham | 23.6% | 13D | Jan 23, 2025 | filing ↗ | |
| The PVBQ Living Trust | 11.2% | 13D | Jan 23, 2025 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Quang X. Pham | $148K | Jun 15, 2026 | filing ↗ |
| Quang X. Pham | $349K | May 11, 2026 | filing ↗ |
| Matthew K Szot | $74K | Dec 29, 2025 | filing ↗ |
| Matthew Szot | $25K | Oct 27, 2025 | filing ↗ |
| Quang X. Pham | $18K | Oct 27, 2025 | filing ↗ |
| Matthew Szot | $25K | Oct 24, 2025 | filing ↗ |
| Quang X. Pham | $16K | Oct 24, 2025 | filing ↗ |
| Matthew Szot | $25K | Oct 13, 2025 | filing ↗ |
| Quang X. Pham | $25K | Oct 13, 2025 | filing ↗ |
| Matthew Szot | $24K | Oct 9, 2025 | filing ↗ |
| Quang X. Pham | $25K | Oct 9, 2025 | filing ↗ |
| Matthew Szot | $2K | Oct 6, 2025 | filing ↗ |
| Quang X. Pham | $7K | Oct 2, 2025 | filing ↗ |
| Matthew Szot | $24K | Oct 1, 2025 | filing ↗ |
| Quang X. Pham | $12K | Oct 1, 2025 | filing ↗ |
| Matthew Szot | $1K | Sep 29, 2025 | filing ↗ |
| Quang X. Pham | $6K | Sep 29, 2025 | filing ↗ |
| Matthew Szot | $150K | Sep 25, 2025 | filing ↗ |
| Quang X. Pham | $96K | Sep 25, 2025 | filing ↗ |
| Matthew Szot | $21K | Sep 24, 2025 | filing ↗ |
| Quang Pham | $36K | Sep 24, 2025 | filing ↗ |
| Quang X. Pham | $17K | Aug 28, 2025 | filing ↗ |
| Matthew Szot | $6K | Aug 28, 2025 | filing ↗ |
| Quang X. Pham | $53K | Aug 27, 2025 | filing ↗ |
| Matthew Szot | $22K | Aug 27, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Reg FD disclosure (7.01) | Jul 21, 2026 | filing ↗ |
| Other events (8.01) | Jul 21, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 21, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jul 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 14, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jul 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 7, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 30, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jun 30, 2026 | filing ↗ |
| Other events (8.01) | Jun 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 30, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 25, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 18, 2026 | filing ↗ |
| Other events (8.01) | Jun 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 18, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 28, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 28, 2026 | filing ↗ |
| Earnings (2.02) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 30, 2026 | filing ↗ |
| Other events (8.01) | Apr 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 30, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 31, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Mar 31, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Mar 31, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 31, 2026 | filing ↗ |
| Earnings (2.02) | Mar 31, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 31, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 12, 2026 | filing ↗ |